The contradictory results from studies which addressed CLDNs expression concerning molecular subtypes [35–38, 40, 41, 43, 44], present findings could add an insight focusing on the association of CLDN-1-CLDN-4 and ROCK-CLDN-2 connected to breast tumors characterized by hormone receptor-positive. Here, CLDN2 is linked to breast neoplasm.